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ABSTRACT 
 
The study was carried out to determine the prevalence of MRSA, VRSA and their current antimicrobial susceptibility 
pattern to various non-β-lactam antimicrobial agents to record the current status of MRSA response to commonly used 
antistaphylococcal antibiotics in Aligarh, India for a period of two years. A total of 430 Staphylococcus aureus strains 
were isolated from various clinical samples. Two hundred ninety (67.44%) of S. aureus were isolated from pus and most 
of these were from orthopaedics 124 (28.85%) and surgery wards 99 (23.02%). One hundred thirty eight (32.09%) 
strains were confirmed to be methicillin resistant by both phenotypic and genotypic methods.  More than 80% of MRSA 
strains were multidrug resistant. However, all were uniformly sensitive to vancomycin and linezolid. Levofloxacin was the 
drug  found  to  be  resistant  in  just  16.47%  MRSA  strains.  Vancomycin  is  the  drug  of  choice  for  MRSA  treatment. 
However,  regular  screening  should  be  done  for  vancomycin  intermediate  and  vancomycin  resistant  strains  of 
Staphylococcus aureus .We suggest the use of levofloxacin for MRSA treatment since overuse of vancomycin can lead 
to the development of vancomycin resistance and more importantly it is beyond the scope of poor patients in developing 
countries like India. 
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INTRODUCTION 
 
Staphylococcus aureus is an important human pathogen 
causing  pyogenic,  disseminated  and  toxin  mediated 
infections  (Oliveira  et  al.,  2001;  Enright  et  al.,  2002; 
Robinson  et  al.,  2003).  The  spectrum  of  S.  aureus 
infections includes food poisoning, meningitis (Betley et al., 
1992; Ish-Horowicz, 1992; Collee et al., 2006), toxic shock 
syndrome (Betley et al., 1992; Collee et al., 2006), as well 
as dermatological disorders ranging from minor infections 
and eczema to blisters and scalded skin syndrome (Winn 
et  al.,  2006).  Infections  caused  by  S.  aureus  used  to 
respond  to  β-lactam  and  related  group  of  antibiotics. 
However  due  to  development  of  methicillin  resistance 
amongst  S. aureus  isolates  (MRSA);  treatment  of  these 
infections  has  become  problematic.  MRSA  is  a  serious 
threat  to  the  hospitalised  patients  globally  and  it  now 
represents  a  challenge  for  public  health  as  community 
associated infections appear to be on the increase in both 
adults  and  children  (Layton  et  al.,  1995).  Currently 
treatment options for MRSA infections are limited to very 
few and expensive drugs like teicoplanin and vancomycin. 
Already resistant to multiple classes of antibiotics , MRSA 
had  been  reported  to  acquire  resistance  even  to 
vancomycin (Asadullah et al., 2003), so in the near future 
the  treatment  options  for  MRSA  infections  are  going  to 
shrink further. The development of resistance to multiple 
antibiotics and control of disease transmission by MRSA 
isolates in hospitals or communities have been recognised 
as  a  major  challenge  as  the  bacterial  population  that 
expresses  the  resistance  varies  according  to  the 
environmental conditions (Qureshi et al., 2004). Therefore 
the  knowledge  of  prevalence  of  MRSA  and  VRSA  and 
their  antimicrobial  profile  become  necessary  in  the 
selection  of  appropriate  empirical  therapy  of  these 
infections.  We  determined  the  prevalence  of  MRSA, 
VRSA and their current antimicrobial susceptibility pattern 
to various non-β-lactam antimicrobial agents to record the 
current  status  of  MRSA  response  to  commonly  used 
antistaphylococcal antibiotics in western UP, India. 
 
MATERIALS AND METHODS 
 
The  present  study  was  conducted  in  the  department  of 
Microbiology,  J.N.  Medical  College  and  Hospital,  AMU, 
Aligarh during the period from August 2005 to July 2007. 
Various  clinical  specimens  such  as  pus,  blood,  urine, 
CSF,  pleural  fluid,  peritoneal  fluid,  ascitic  fluid,  bile, 
cervical swab, semen, conjunctival swabs and ear swabs 
received in the Microbiology laboratory were studied. The 
samples  were  cultured  on  5–10%  sheep  blood  agar, 
MacConkey  agar,  Mannitol  salt  agar  and  Robertson’s 
cooked  meat  broth.  Only  those  specimens  from  which 
staphylococci were isolated were included in the study. All 
the isolates suggestive of S. aureus were identified by the 
standard biochemical procedures (Collee et al, 2006). The 
methicillin susceptible strain ATCC 25923 was used as a 
control  for  the  diagnostic  procedures.  All  isolates  were 
maintained in 0.5%–1% semisolid nutrient agar stabs and 
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seeded with cork stoppers soaked with hot sterile paraffin 
until analysed (Colle and Miles, 1989). 
 
Oxacillin disc diffusion test 
 
All the isolates were subjected to oxacillin disc diffusion 
test using oxacillin  1  µg  disc.  A  0.5  McFarland  turbidity 
standard suspension of  the  isolate  was made  and  lawn 
culture  was  done  on  Mueller-Hinton  agar  (MHA)  plates 
containing 4% NaCl. Plates were incubated at 37 ° C for 
18  h  and  zone  diameters  were  measured.  An  inhibition 
zone  diameter  of  ≤  10  mm  was  reported  as  methicillin 
resistant and ≥ 13 mm was taken as methicillin sensitive. 
 
MIC determination of oxacillin 
 
MIC  was  determined  by  agar  dilution  test.  10  different 
dilutions  of  oxacillin  were  selected  such  that  the 
concentrations  that  allowed  determination  of  MIC 
breakpoints defining susceptible (≤ 2 µg/mL) (CLSI, 2004) 
and  resistant  (≥  4  µg/mL)  (CLSI,  2004)  values  were 
included. Lowest concentration at which the growth was 
inhibited by 80% or more was recorded as MIC. 
 
PCR amplification for mec A and fem B genes 
 
Multiplex PCR (Geha et al., 1994) was carried out on all 
the  S.  aureus  strains  found  methicillin  resistant  on  MIC 
determination. All the MRSA strains were for the mec A 
and  femB  genes  using    the  following  oligonucleotides 
sequence.mec A1-5’ GTA GAA ATG ACT GAA CGT CCG 
ATA A-3’, mec A2-5’ CCA ATT CCA CAT TGT TTC CGT 
CTA A-3’, fem B1-5’ TTA CAG AGT TAA CTG TTA CC-3’, 
fem B2-5’ ATA CAA ATC CAG CAC GCT CT-3’. A 50 µL 
PCR  reaction  mixture  consisted  of  45  µL  of  mastermix 
containing PCR buffer (1X), d NTP mix (0.2 mM of each), 
primer  (0.5  µM),  Taq  DNA  polymerase  (0.25  U),  and 
MgCl2  (1.5  mM)  with  5  µL  of  template  DNA.  Cycling 
parameters of PCR were set as follows: hot start 94 ° C for 
4 min followed by 35 cycles of melting at 94 ° C for 45 s, 
annealing at 50 ° C for 45 s, and extension at 72 ° C for 1 
min.  Analysis  of  amplified  products  was  done  by  gel 
electrophoresis. Amplicons of 310 bp were consistent with 
mec A and of 651 bp with fem B gene amplification. 
 
Screening of vancomycin resistance 
 
Himartshu Method 
 
Overnight grown cultures were adjusted to 0.5 McFarland 
approximately  1.5  x  10
8  cfu/mL  and  10  µL  spots  was 
inoculated on BHI agar containing 4 µg/mL of vancomycin. 
The  plates  were  incubated  at  35  ° C  for  24–48  h. 
Appearance  of  any  growth  indicated  vancomycin 
resistance (Wootton et al., 2001). 
 
CDC Method 
 
Overnight grown cultures were adjusted to 0.5 Mc-Farland 
approximately 1.5 x 10
8 cfu/mL and diluted 100 times to 
get an inoculum of approximately 1.5 x 10
6 cfu/mL. Ten µL 
spots  of  the  cultures  were  inoculated  on  BHI  agar 
containing  6  µg/mL  of  vancomycin.  The  plates  were 
incubated at 35 ° C for 24–48 h. Appearance of any growth 
indicated vancomycin resistance (Tenover et al., 2001). 
 
Method by Tenover et al. (2001) 
 
Overnight grown cultures were adjusted to 0.5 Mc-Farland 
1.5 x 10
8 cfu/mL and diluted 100 times to get an inoculum 
of  approximately  1.5  x  10
6.  Ten  µL  of  both  the  above 
mentioned inoculums were spot inoculated on MHA agar 
containing  5  µg/mL  of  vancomycin.  The  plates  were 
incubated at 35 ° C for 24–48 h. Appearance of any growth 
indicated vancomycin resistance (Huber et al., 1999). 
 
MIC determination of vancomycin 
 
Vancomycin MICs for the clinical isolates were determined 
by agar dilution method in Mueller Hinton agar according 
to  the  protocol  of  National  committee  for  Clinical 
Laboratory Standards (NCCLS). Eight different dilutions of 
van-comycin were selected such that the concentrations 
that  allowed  determination  of  MIC  breakpoints  defining 
susceptible  (≤  4  µg/mL)  (Tenover  et  al.,  2001), 
intermediate  (8–16  µg/mL)  (Tenover  et  al.,  2001)  and 
resistant (≥ 32 µg/mL) (Tenover et al., 2001) values were 
included. Lowest concentration at which the growth was 
inhibited by 80% or more was recorded as MIC. 
Antibiotic susceptibility testing of all the MRSA strains 
was  done  using  Kirby  Bauer’s  disk  diffusion  method 
(CLSI, 2000) for the following non-β-lactam antimicrobial 
agents: amikacin 30 µg, ciprofloxacin 5 µg, clindamycin 2 
µg, cotrimoxazole 25 µg, erythromycin 15 µg, gatifloxacin 
5 µg, gentamycin 10 µg, levofloxacin 5 µg, linezolid 30 µg, 
ofloxacin  5  µg,  sparfloxacin  5  µg,  tobramycin  10  µg, 
vancomycin 30 µg. 
 
RESULTS  
 
A total of 430 S. aureus were isolated from various clinical 
specimens.  The  majority  of  S.  aureus  strains  were 
isolated  from  pus  290  (67.44%)  followed  by  urine  62 
(14.42%)  and  blood  49  (11.39%)  (Table  1)  and  around 
50% of these were from the orthopaedics 124 (28.85%) 
and the surgery wards 99 (23.02%) (Table 2). Out of 430 
S.  aureus  strains  143  (33.25%)  were  found  to  be 
methicillin  resistant  on  phenotypic  detection  by  oxacillin 
disc diffusion test. However, on genotypic detection with 
the help of multiplex PCR 138 (32.09%) strains had both 
mec A (310 bp) and fem B (651 bp) and were confirmed 
to be methicillin resistant. MIC of all the MRSA isolates 
was more than 4 µg/mL but none was greater than 256 
µg/mL.  Prevalence  of  MRSA  was  highest  amongst  the 
orthopaedics  64  (46.38%)  and  the  surgery  49  (35.50%) 
wards (Table 2). Out of 138 MRSA strains 112 (81.16%) 
were  MDR-MRSA  (resistant  to  >  3  non-β-lactam 
antibiotics  belonging  to  different  groups)  and  only  26 
(18.84%) strains were non-MDR-MRSA (Table 3). Among 
the  multidrug-resistant  isolates  maximum  21  (15.22%) Mal. J. Microbiol. Vol 7(2) 2011, pp. 66-70 
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Table 1: Isolation rate of S. aureus in relation to specimen 
(n=430) 
Specimen  No. of isolates (%) 
Pus (P)  290 (67.44) 
Blood (B)  49 (11.39) 
Endocervical swab (Cx)  1 (0.23) 
Ear swab (E)  2 (0.47) 
Urine (U)  62 (14.42) 
CSF (CSF)  7 (1.63) 
Conjunctival swab (Cj)  2 (0.47) 
Drain tip (Dt)  1 (0.23) 
Foley’s tip (Ft)  2 (0.47) 
Fluids (Pleural, ascitic, peritoneal)  0 (0.00) 
Sputum and throat swab  1 (0.23) 
Seminal fluid  2 (0.47) 
Catheter tip  11 (2.5) 
Umblical tip  1 (0.23) 
Total  262 (100) 
 
Table 2: Isolation rate of S. aureus from various wards in 
hospital 
Hospital wards 
Non- MRSA  MRSA  S. 
aureus 
N (%)  N (%)  N 
Orthopaedics  66 (53.23)  58 (46.77)  124 
Surgery  64 (64.65)  35 (33.35)  99 
Paediatrics  27 (72.97)  10 (27.03)  37 
Gynaecology  29 (75.32)  9 (23.68)  38 
Medicine  15 (75.00)  5 (25.00)  20 
ICU  6 (54.55)  4 (45.45)  11 
ENT  12 (70.59)  5 (29.41)  17 
TB and Chest  10 (100.00)  0 (0.00)  10 
Ophthalmology  9 (90.00)  1 (10.00)  10 
Skin  20 (95.24)  1 (4.76)  21 
Plastic surgery 
(Burn)  15 (65.22)  8 (34.78)  23 
Nursery  19 (95)  1 (5)  20 
Total  292 (67.91)  138 (32.09)  430 
Table 3: Pattern of resistance of MRSA isolates to other 
drugs (n = 138) 
No. of other drugs  No. of MRSA isolates (%) 
n
 
M
D
R
  0  0 (0.00) 
1  6 (4.35) 
2  8 (5.80) 
3  12 (8.69) 
M
D
R
 
4  9 (6.52) 
5  21 (15.22) 
6  16 (11.59) 
7  9 (6.52) 
8  20 (14.49) 
9  17 (12.32) 
10  14 (10.14) 
11  6 (3.62) 
12  0 (0.00) 
Total  138 (100.00) 
were resistant to five antibiotics. Maximum resistance was 
shown to cotrimoxazole (89.41%) followed by clindamycin 
(83.53%). Among the quinolones ciprofloxacin was found 
to be at the bottom of the list with maximum resistance of 
81.17%,  followed  by  gatifloxacin  (45.88%),  sparfloxacin 
(38.88%), and ofloxacin (23.53%). Levofloxacin was found 
to  be  the  best  amongst  the  flouroquinolones  with  just 
16.47%  resistance.  Amikacin  was  better  at  60.00% 
resistance  among  the  aminoglycosides  with  gentamicin 
showing resistance to 69.41% and tobramicin to 71.00% 
strains. Linezolid and vancomycin were the only two drugs 
to which all the strains of MRSA were uniformly sensitive. 
On screening for vancomycin resistance it was found that 
11 (7.97%) strains of MRSA were resistant to vancomycin 
by the Himartshu method, and 8 (5.7%) by the method by 
Tenover and co-workers. However CDC method detected 
no  vancomycin  intermediate  (VISA)  or  vancomycin 
resistant  (VRSA)  strains  of  S.  aureus  which  was  in 
correlation  with  MIC  of  vancomycin  by  the  agar  dilution 
method. The MIC for vancomycin of all the MRSA strains 
was found to be less than 4 µg/mL. 
 
DISCUSSION 
 
MRSA is  a  major  pathogen causing significant  mortality 
and  morbidity  in  the  hospitals  as  well  as  among  the 
communities. Many of the MRSA are becoming multidrug 
resistant  and  are  susceptible  only  to  glycopeptides 
antibiotics such as vancomycin (Mehta et al., 1998). Low 
level  resistance  even  to  vancomycin  is  emerging  at 
present (Asadullah et al., 2003). The prolonged hospital 
stay, indiscriminate use of antibiotics, receipt of antibiotics 
before  coming  to  the  hospital  etc.  are  the  possible 
predisposing  factors  of  MRSA  emergence  (Anupurba  et 
al., 2003). The prevalence of MRSA in our hospital was 
found to be 32.44%. Similar rate of MRSA isolation had 
also been reported from other parts of India (Anbumani et 
al., 2006; Dar et al., 2006; Gopalakrishnan et al., 2006; 
Oberoi and Varghese, 2006). However, a higher rate (of 
around  50%)  of  MRSA  prevalence  is  reported  in  some 
studies (Anupurba et al., 2003; Vidhani, 2001; Krishnan, 
2002).  The  high  prevalence  of  MRSA  in  these  studies 
could be due to several factors like indiscriminate use of 
antibiotics and unethical treatment before coming to the 
hospital. 
In the present study maximum isolates of S. aureus 
were  from  pus  (77.87%).  This  justifies  the  fact  that  S. 
aureus  is  a  known  cause  of  wound  infections.  Rate  of 
MRSA isolation was also highest among the pus samples 
especially from the orthopaedics, surgery wards and the 
ICU. This might be because the patients in these wards 
are usually with open wounds and are debilitated. They 
undergo multiple interventions in the hospital which further 
increases  the  risk  of  MRSA  infection  due  to  multiple 
people involved as well as prolonged stay in the wards. 
Along with these factors, the patient is usually on multiple 
antibiotics. On antimicrobial sensitivity testing it was found 
the  MRSA  isolates  were  resistant  to  multiple  groups  of 
antibiotics.  Around  80%  of  the  strains  were  resistant  to 
more  than  three  non-β-lactam  antibiotics  and  were Mal. J. Microbiol. Vol 7(2) 2011, pp. 66-70 
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multidrug resistant. However all the strains were uniformly 
sensitive to linezolid and vancomycin. Such an incidence 
of  multidrug  resistance  had also  been  reported  in  other 
studies from North India (Vidhani, 2001; Dar et al., 2006). 
Among the flouroquinolones ciprofloxacin was reported to 
have highest resistance of 81.17%. Similar to our findings, 
a  high  resistance  of  90–98%  had  been  reported  for 
ciprofloxacin  in  other  studies  (Pulimood  et  al.,  1996; 
Qureshi  et  al.,  2004).  Among  the  aminoglycosides 
gentamicin  had  been  reported  to  be  resistant  in  63.6% 
isolates by Rajaduraipandi and co-workers (2006), similar 
to our findings. However some authors had quoted up to 
97.8% resistance to gentamicin which is higher compared 
to ours (Qureshi et al., 2004). Linezolid and vancomycin 
were the only drugs to which all the strains were sensitive. 
However  some  authors  had  reported  emerging 
vancomycin resistance with strains showing intermediate 
[VRSA]  and  complete  resistance  to  vancomycin  [VISA] 
(Asadullah et al., 2003; Gopalakrishnan, 2006). At present 
the proportion of MRSA with reduced susceptibility [VISA] 
to vancomycin is well known. Vancomycin resistance can 
be  difficult  to  detect  in  clinical  microbiology  laboratories 
since  sensitivity  testing  by  disc  diffusion  method  may 
sometimes  misclassify  intermediate  susceptible  isolates 
as fully susceptible. MIC determination by agar and broth 
dilution  methods  is  considered  the  gold  standard 
(Srinivasan et al., 2002) but it is beyond the scope of most 
of  the  micro-biology  laboratories  especially  in  the 
developing  countries  like  India.  The  screening  methods 
can  be  used  for  early  and  accurate  detection  of 
vancomycin  resistance.  Among  the  three  screening 
methods evaluated in our study CDC method was found 
to be the most accurate with maximum correlation with the 
MIC  of  vancomycin  detected  by  agar  dilution  method. 
Himartshu  method  and  the method  by  Tenover  and co-
workers  (2001)  were  found  to  be  false  positive  in  11 
(7.97%)  and  8  (5.7%)  isolates  respectively.  We 
recommend  the  use  of  the  CDC  method  for  regular 
screening  for  vancomycin  resistance  in  all  the 
microbiology  laboratories.  However,  confirmation  of 
vancomycin  resistance  should  be  done  by  the 
determination of MIC in all the isolates suspected to have 
VISA or VRSA. But overuse of vancomycin can promote 
the emergence of its resistance and more importantly in 
developing countries like India poor patients cannot afford 
treatment with these costly drugs. Another limiting factor 
for  vancomycin  use  is  the  high  rate  of  adverse  affects 
caused  by  the  same.  We  suggest  that  no  antimicrobial 
should be used on regular basis for empirical treatment 
because of the rapidly changing pattern of drug resistance. 
So we recommend that proper screening of antimicrobial 
sensitivity  pattern  of  Staphylococcus  species  should  be 
done within each hospital on annual basis and empirical 
antimicrobial therapy should be modified accordingly. The 
next  respon-sibility  goes  to  the  clinicians  who  should 
exercise  caution  in  their  use  of  vancomycin  or  any 
antimicrobial  and  help  to  prevent  the  spread  of  drug 
resistance  by  the  rationale  and  proper  use  of 
antimicrobials.  
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